EPCAM and neoplasm: Earlier foundational work in 2013 on LIM1863 colon carcinoma organoids isolated two distinct EV subpopulations (apical and basolateral), with distinct proteomic profiles, including tumor-promoting complexes such as EpCAM, claudin-7, and CD44, demonstrating spatial and functional heterogeneity of EVs [205].